{"filing":{"accession_number":"0001140361-26-023705","cik":"0001368514","ticker":"ADMA","company_name":"ADMA BIOLOGICS, INC.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"ef20075432_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/ef20075432_8k.htm"},"events":[{"id":7414,"run_id":6514,"accession_number":"0001140361-26-023705","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of ADMA Biologics' 2026 Annual Meeting of Stockholders held on June 2, 2026, including voting outcomes on three proposals: election of two Class I directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides detailed vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","company_name":"ADMA BIOLOGICS, INC.","ticker":"ADMA","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3507,"accession_number":"0001140361-26-023705","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of ADMA Biologics' 2026 Annual Meeting of Stockholders held on June 2, 2026, including voting outcomes on three proposals: election of two Class I directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides detailed vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:12:36.838920+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3507,"accession_number":"0001140361-26-023705","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of ADMA Biologics' 2026 Annual Meeting of Stockholders held on June 2, 2026, including voting outcomes on three proposals: election of two Class I directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides detailed vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:12:36.838920+00:00","company_name":"ADMA BIOLOGICS, INC.","ticker":"ADMA","filing_date":"2026-06-02"}]}